In a groundbreaking development for pediatric oncology, the U.S. Food and Drug Administration (FDA) has approved a clinical trial for Reyobiq (Rhenium Re186 Obisbemeda), a promising radiation therapy aimed at treating aggressive brain tumors in children. This trial has generated significant
In the bustling landscape of modern healthcare, a pivotal challenge centers on effectively engaging patients in behavioral health. What happens when patients struggling with mood disorders or addiction miss appointments and lose touch with their care providers? Recent statistics reveal that over
A groundbreaking event in the realm of correctional healthcare recently unfolded as the Corrections Technology Association (CTA) hosted its 25th Annual Technology Summit. Gathered in anticipation and excitement were industry leaders, innovators, and key stakeholders from various sectors, all
British Columbia's health-care system has been under significant scrutiny as residents increasingly voice their dissatisfaction with the prolonged wait times for medical services. Despite a substantial increase in healthcare spending, which saw a rise of $1.7 billion, bringing the projected
In an era where medical innovation is advancing with unprecedented momentum, TISSIUM’s COAPTIUM CONNECT platform sets a new benchmark in nerve repair technology. Recently granted de novo marketing authorization by the US Food and Drug Administration (FDA), this groundbreaking platform offers a t
The landscape of surgical intervention is continuously evolving, and Levita Magnetics is at the forefront of this transformation with its recent expansion of the MARS (magnetic-assisted robotic surgery) system. With expanded FDA 510(k) clearance, MARS and its Magnetic Surgical System (MSS) are now
